Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2022 ∙ Alonso Castillo, R. Martínez Castrillo, J. C.

Neurological manifestations associated with COVID-19 vaccine

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Cheng, H. Peng, Z. Si, S. Alifu, X. Zhou, H. Chi, P. Zhuang, Y. Mo, M. Yu, Y.

Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis

  • Adults
  • Older adults
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, X. Chen, Z. Azman, A. S. Sun, R. Lu, W. Zheng, N. Zhou, J. Wu, Q. Deng, X. Zhao, Z. Chen, X. Ge, S. Yang, J. Leung, D. T. Yu, H.

Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Induced by Natural Infection or Vaccination: A Systematic Review and Pooled Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Wu, P. C. Huang, I. H. Wang, C. W. Tsai, C. C. Chung, W. H. Chen, C. B.

New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Alhumaid, S. Al Mutair, A. Rabaan, A. A. A. LShakhs FM Choudhary, O. P. Yong, S. J. Nainu, F. Khan, A. Muhammad, J. Alhelal, F. Al Khamees, M. H. Alsouaib, H. A. Al Majhad, A. S. Al-Tarfi, H. R. A. Lyasin AH Alatiyyah, Y. Y. Alsultan, A. A. Alessa, M. E. Alessa, M. E. Alissa, M. A. Alsayegh, E. H. Alshakhs, H. N. Al Samaeel, H. A. AlShayeb, R. A. Alnami, D. A. Alhassan, H. A. Alabdullah, A. A. Alhmed, A. H. AlDera, F. H. Hajissa, K. Al-Tawfiq, J. A. Al-Omari, A.

New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Holzer, M. T. Krusche, M. Ruffer, N. Haberstock, H. Stephan, M. Huber, T. B. Kötter, I.

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Chen, C. C. Chen, C. J.

New-onset inflammatory arthritis after COVID-19 vaccination: A systematic review

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kumari, S. Anand, R. Sambyal, B. Singh, Y. Rangappa, P. Jha, S. K.

Ocular adverse effects of COVID-19 vaccines: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Abu Serhan, H. Abdelaal, A. Abuawwad, M. T. Taha, M. J. J. Irshaidat, S. Abu Serhan, L. Abu-Ismail, L. Abu Salim, Q. F. Abdelazeem, B. Elnahry, A. G.

Ocular Vascular Events following COVID-19 Vaccines: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Di Spirito, F. Amato, A. Di Palo, M. P. Contaldo, M. D'Ambrosio, F. Lo Giudice, R. Amato, M.

Oral Lesions Following Anti-SARS-CoV-2 Vaccination: A Systematic Review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...